DICE insider filings
DICE Therapeutics, Inc. — 27 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2023-08-09. Screen DICE transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for DICE between 2026-07-10 and 2026-10-08. The table below lists the most recent filings on record.
Recent insider filings — DICE Therapeutics, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2023-08-09 | 4 | Simson Jake — Director | Disposition to issuer (D): 21,250 (derivative) | EDGAR |
| 2023-08-09 | 4 | Robertson Scott M. — CFO & CBO | Disposition to issuer (D): 198,000 · Disposition to issuer (D): 7,191 (derivative) · Disposition to issuer (D): 771 (derivative) · Disposition to issuer (D): 20,751 (derivative) · Disposition to issuer (D): 2,688 (derivative) · Disposition to issuer (D): 9,095 (derivative) · +6 more | EDGAR |
| 2023-08-09 | 4 | Timothy Lu — CMO | Disposition to issuer (D): 152,285 · Disposition to issuer (D): 31,304 (derivative) · Disposition to issuer (D): 25,593 (derivative) · Disposition to issuer (D): 43,167 (derivative) · Disposition to issuer (D): 157,756 (derivative) · Disposition to issuer (D): 90,000 (derivative) · +1 more | EDGAR |
| 2023-08-09 | 4 | Jacobsen John R. — CSO | Disposition to issuer (D): 147,497 · Disposition to issuer (D): 4,367 (derivative) · Disposition to issuer (D): 922 (derivative) · Disposition to issuer (D): 1,278 (derivative) · Disposition to issuer (D): 4,229 (derivative) · Disposition to issuer (D): 1,344 (derivative) · +8 more | EDGAR |
| 2023-08-09 | 4 | Doyle Mittie — Director | Disposition to issuer (D): 42,500 (derivative) | EDGAR |
| 2023-08-09 | 4 | Bowers Lisa — Director | Disposition to issuer (D): 42,500 (derivative) | EDGAR |
| 2023-08-09 | 4 | Judice Kevin — CEO, Director | Disposition to issuer (D): 799,685 · Disposition to issuer (D): 20,464 (derivative) · Disposition to issuer (D): 16,661 (derivative) · Disposition to issuer (D): 131,027 (derivative) · Disposition to issuer (D): 132,074 (derivative) · Disposition to issuer (D): 384,900 (derivative) · +2 more | EDGAR |
| 2023-08-09 | 4 | Scopa James Paul — Director | Disposition to issuer (D): 15,199 · Disposition to issuer (D): 25,722 · Disposition to issuer (D): 12,096 (derivative) · Disposition to issuer (D): 8,261 (derivative) · Disposition to issuer (D): 13,800 (derivative) · Disposition to issuer (D): 21,250 (derivative) | EDGAR |
| 2023-08-09 | 4 | TETLOW SHARON — Director | Disposition to issuer (D): 49,841 · Disposition to issuer (D): 12,096 (derivative) · Disposition to issuer (D): 8,261 (derivative) · Disposition to issuer (D): 13,800 (derivative) · Disposition to issuer (D): 21,250 (derivative) | EDGAR |
| 2023-08-09 | 4 | RA CAPITAL MANAGEMENT, L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II, L.P. Kolchinsky Peter Shah Rajeev M. | Code (U): 7,070,205 · Code (U): 786,407 · Disposition to issuer (D): 21,250 (derivative) | EDGAR |
| 2023-08-09 | 4 | SCHELLER RICHARD H — Director | Disposition to issuer (D): 8,427 · Disposition to issuer (D): 4,357 (derivative) · Disposition to issuer (D): 9,138 (derivative) · Disposition to issuer (D): 8,261 (derivative) · Disposition to issuer (D): 22,600 (derivative) · Disposition to issuer (D): 31,250 (derivative) | EDGAR |
| 2023-08-03 | 4 | Scopa James Paul — Director | Gift (G): 220 @ $0 · Gift (G): 2,200 @ $0 | EDGAR |
| 2023-07-19 | 4 | Scopa James Paul — Director | Gift (G): 2,200 @ $0 | EDGAR |
| 2023-07-13 | 4 | Scopa James Paul — Director | Gift (G): 300 @ $0 | EDGAR |
| 2023-06-23 | 4 | Northpond Ventures GP, LLC — 10% owner Northpond Ventures, LP — 10% owner Northpond Ventures GP II, LLC — 10% owner Northpond Ventures II, LP — 10% owner Rubin Michael P. — 10% owner | Sale (S): 1,969,368 @ $46.50 · Sale (S): 523,503 @ $46.50 | EDGAR |
| 2023-06-02 | 4 | Jacobsen John R. — CSO | Sale (S): 14,307 @ $30.31 · Sale (S): 4,443 @ $31.24 | EDGAR |
| 2023-05-09 | 4 | SCHELLER RICHARD H — Director | Sale (S): 84,097 @ $38.51 | EDGAR |
| 2023-05-05 | 4 | Robertson Scott M. — CFO & CBO | Sale (S): 18,750 @ $36.55 | EDGAR |
| 2023-05-05 | 4 | Timothy Lu — CMO | Sale (S): 10,000 @ $36.54 | EDGAR |
| 2023-05-05 | 4 | Judice Kevin — CEO, Director | Sale (S): 13,698 @ $36.50 | EDGAR |
| 2023-05-02 | 4 | Scopa James Paul — Director | Gift (G): 6,923 @ $0 · Gift (G): 6,923 @ $0 | EDGAR |
| 2023-04-19 | 4 | Jacobsen John R. — CSO | Sale (S): 16,392 @ $30.08 | EDGAR |
| 2023-04-04 | 4 | Jacobsen John R. — CSO | Sale (S): 773 @ $30 | EDGAR |
| 2023-03-30 | 4 | Jacobsen John R. — CSO | Sale (S): 500 @ $30.09 · Sale (S): 1,094 @ $30.00 | EDGAR |
| 2023-03-30 | 4 | RA CAPITAL MANAGEMENT, L.P. — Director, 10% owner RA Capital Healthcare Fund LP — Director, 10% owner RA Capital Nexus Fund II, L.P. — Director, 10% owner Kolchinsky Peter — Director, 10% owner Shah Rajeev M. — Director, 10% owner | Purchase (P): 246,779 @ $29.24 · Purchase (P): 66,369 @ $29.38 · Purchase (P): 195,997 @ $28.74 | EDGAR |
| 2023-03-27 | 4 | RA CAPITAL MANAGEMENT, L.P. — Director, 10% owner RA Capital Healthcare Fund LP — Director, 10% owner RA Capital Nexus Fund II, L.P. — Director, 10% owner Kolchinsky Peter — Director, 10% owner Shah Rajeev M. — Director, 10% owner | Purchase (P): 155,089 @ $26.67 · Purchase (P): 192,335 @ $26.87 · Purchase (P): 151,132 @ $27.48 | EDGAR |
| 2023-03-21 | 4 | Scopa James Paul — Director | Gift (G): 30,719 @ $0 · Gift (G): 30,719 @ $0 · Sale (S): 10,000 @ $29.05 | EDGAR |
Recent 8-K events — DICE Therapeutics, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2023-08-09 | 8-K | 1.02 — Termination of a Material Definitive Agreement 2.01 — Completion of Acquisition or Disposition of Assets 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 3.03 — Material Modification to Rights of Security Holders 5.01 — Changes in Control of Registrant 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-06-20 | 8-K | 1.01 — Entry into a Material Definitive Agreement 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-06-07 | 8-K | 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-05-11 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-03-15 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=DICE returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →